Welcome to medications.com

Lundbeck posts strong profit growth despite UK facility writedown - Pharma Times (subscription)

Revenues for 2007 were up 19% to 10.99 billion kroner, helped by another strong showing of the blockbuster antidepressant Lexapro (escitalopram), ...

http://www.pharmatimes.com/WorldN... | Posted: Wed Mar 05 06:08:04 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com